Synergy’s BioSphere Putty Secures Regulatory Clearance in Australia

Synergy Biomedical received clearance from Australia’s Therapeutic Goods Administration for its bioactive bone graft product BioSphere Putty.

The product uses spherical bioactive glass particles to create a moldable bone graft putty that improves bone formation.

The product previously received FDA and CE Mark clearances, and has been on the market since 2013.